Physician profile
Visharad Patel
NPI 1437554698
$10,889.98
in general payments reported to CMS, 2019-2025
29 companies · $769 in 2025
The $769 reported for 2025 was less than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $3,457 · 2021: $255 · 2022: $530 · 2023: $5,298 · 2024: $581 · 2025: $769.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Honoraria: $3,200 · Food and Beverage: $2,337 · Travel and Lodging: $1,111.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Honoraria | $3,200.00 |
| Food and Beverage | $2,336.75 |
| Travel and Lodging | $1,111.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Philips North America LLC | $4,901.93 | 2022-2023 | (6554) Periph Vasc Undiv |
| Medtronic Vascular, INC. | $3,457.33 | 2020 | |
| Medtronic, INC. | $731.56 | 2021-2025 | Endurant Iis, Venaseal, Interstim |
| Boston Scientific Corporation | $363.68 | 2023-2025 | Varithena Administration Pack, Enroute Transcarotid Stent, Eluvia |
| Janssen Pharmaceuticals, INC | $217.81 | 2021-2024 | Xarelto |
| Silk Road Medical, INC. | $146.52 | 2023-2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| Imperative Care, INC | $135.54 | 2025 | Symphony Catheter |
| Angiodynamics, INC. | $133.20 | 2021-2022 | |
| Surmodics, INC. | $115.93 | 2024 | Pounce Thrombectomy |
| Neuros Medical, INC. | $70.80 | 2025 | Altius |
| Penumbra, INC. | $64.77 | 2023-2025 | Ruby Coil, Indigo System, Penumbra System |
| Bard Peripheral Vascular, INC. | $62.15 | 2021-2024 | Fluency Endovascular Stent Graft |
| W. L. Gore & Associates, INC. | $56.19 | 2021-2025 | Gore Excluder Iliac Branch Endoprosthesis, Excluder Conformable Aaa Endoprosthesis With Active Control |
| Baxter Healthcare | $53.59 | 2024 | Renal - Chronic |
| E.R. Squibb & Sons, L.L.C. | $40.54 | 2022-2024 | Eliquis |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $38.20 | 2024 | |
| Cardiva Medical, INC. | $38.19 | 2023-2025 | Cardiva Vascade 5f Vcs, Cardiva Vascade 6/7f Vcs |
| Shockwave Medical, INC | $36.93 | 2025 | |
| Pfizer INC. | $36.64 | 2021-2022 | |
| Getinge USA Sales, LLC | $32.10 | 2021-2022 | |
| Veryan Medical Incorporated | $28.10 | 2023 | Biomimics 3d Vascular Stent System |
| Mozarc Medical US LLC | $21.49 | 2024 | Permcath |
| Reflow Medical INC | $17.98 | 2025 | |
| Flowphysix INC | $16.25 | 2025 | Flowrunner |
| Argon Medical Devices, INC. | $15.98 | 2025 | Clot Management |
| Lemaitre Vascular, INC. | $15.07 | 2023 | Artegraft Vascular Graft |
| Cordis US Corp. | $15.01 | 2023 | Brite Tip Radianz |
| Terumo Medical Corporation | $14.73 | 2024 | Glidewire, Azur Cx Detachable |
| Cardiovascular Systems INC. | $11.77 | 2023 | Diamondback Peripheral |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Visharad Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.